Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Metabolic Disease Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Metabolic Disease Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Metabolic Disease Therapeutics Overall Market Size
2.1 Global Metabolic Disease Therapeutics Market Size: 2021 VS 2028
2.2 Global Metabolic Disease Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Metabolic Disease Therapeutics Players in Global Market
3.2 Top Global Metabolic Disease Therapeutics Companies Ranked by Revenue
3.3 Global Metabolic Disease Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Metabolic Disease Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Metabolic Disease Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Metabolic Disease Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Metabolic Disease Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Metabolic Disease Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Metabolic Disease Therapeutics Market Size Markets, 2021 & 2028
4.1.2 Glycogen Metabolism Disease Drug
4.1.3 Lipid Metabolism Disease Drug
4.1.4 Amino Acid Metabolism Drug
4.1.5 Other
4.2 By Type - Global Metabolic Disease Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Metabolic Disease Therapeutics Revenue, 2017-2022
4.2.2 By Type - Global Metabolic Disease Therapeutics Revenue, 2023-2028
4.2.3 By Type - Global Metabolic Disease Therapeutics Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Metabolic Disease Therapeutics Market Size, 2021 & 2028
5.1.2 Hospital Pharmacy
5.1.3 Retail Pharmacy
5.2 By Application - Global Metabolic Disease Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Metabolic Disease Therapeutics Revenue, 2017-2022
5.2.2 By Application - Global Metabolic Disease Therapeutics Revenue, 2023-2028
5.2.3 By Application - Global Metabolic Disease Therapeutics Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Metabolic Disease Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Metabolic Disease Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Metabolic Disease Therapeutics Revenue, 2017-2022
6.2.2 By Region - Global Metabolic Disease Therapeutics Revenue, 2023-2028
6.2.3 By Region - Global Metabolic Disease Therapeutics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Metabolic Disease Therapeutics Revenue, 2017-2028
6.3.2 US Metabolic Disease Therapeutics Market Size, 2017-2028
6.3.3 Canada Metabolic Disease Therapeutics Market Size, 2017-2028
6.3.4 Mexico Metabolic Disease Therapeutics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Metabolic Disease Therapeutics Revenue, 2017-2028
6.4.2 Germany Metabolic Disease Therapeutics Market Size, 2017-2028
6.4.3 France Metabolic Disease Therapeutics Market Size, 2017-2028
6.4.4 U.K. Metabolic Disease Therapeutics Market Size, 2017-2028
6.4.5 Italy Metabolic Disease Therapeutics Market Size, 2017-2028
6.4.6 Russia Metabolic Disease Therapeutics Market Size, 2017-2028
6.4.7 Nordic Countries Metabolic Disease Therapeutics Market Size, 2017-2028
6.4.8 Benelux Metabolic Disease Therapeutics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Metabolic Disease Therapeutics Revenue, 2017-2028
6.5.2 China Metabolic Disease Therapeutics Market Size, 2017-2028
6.5.3 Japan Metabolic Disease Therapeutics Market Size, 2017-2028
6.5.4 South Korea Metabolic Disease Therapeutics Market Size, 2017-2028
6.5.5 Southeast Asia Metabolic Disease Therapeutics Market Size, 2017-2028
6.5.6 India Metabolic Disease Therapeutics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Metabolic Disease Therapeutics Revenue, 2017-2028
6.6.2 Brazil Metabolic Disease Therapeutics Market Size, 2017-2028
6.6.3 Argentina Metabolic Disease Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Metabolic Disease Therapeutics Revenue, 2017-2028
6.7.2 Turkey Metabolic Disease Therapeutics Market Size, 2017-2028
6.7.3 Israel Metabolic Disease Therapeutics Market Size, 2017-2028
6.7.4 Saudi Arabia Metabolic Disease Therapeutics Market Size, 2017-2028
6.7.5 UAE Metabolic Disease Therapeutics Market Size, 2017-2028
7 Players Profiles
7.1 Merck
7.1.1 Merck Corporate Summary
7.1.2 Merck Business Overview
7.1.3 Merck Metabolic Disease Therapeutics Major Product Offerings
7.1.4 Merck Metabolic Disease Therapeutics Revenue in Global Market (2017-2022)
7.1.5 Merck Key News
7.2 Novartis
7.2.1 Novartis Corporate Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Metabolic Disease Therapeutics Major Product Offerings
7.2.4 Novartis Metabolic Disease Therapeutics Revenue in Global Market (2017-2022)
7.2.5 Novartis Key News
7.3 Takeda Pharmaceutical
7.3.1 Takeda Pharmaceutical Corporate Summary
7.3.2 Takeda Pharmaceutical Business Overview
7.3.3 Takeda Pharmaceutical Metabolic Disease Therapeutics Major Product Offerings
7.3.4 Takeda Pharmaceutical Metabolic Disease Therapeutics Revenue in Global Market (2017-2022)
7.3.5 Takeda Pharmaceutical Key News
7.4 Astra Zeneca
7.4.1 Astra Zeneca Corporate Summary
7.4.2 Astra Zeneca Business Overview
7.4.3 Astra Zeneca Metabolic Disease Therapeutics Major Product Offerings
7.4.4 Astra Zeneca Metabolic Disease Therapeutics Revenue in Global Market (2017-2022)
7.4.5 Astra Zeneca Key News
7.5 Beohrigher Ingelheim
7.5.1 Beohrigher Ingelheim Corporate Summary
7.5.2 Beohrigher Ingelheim Business Overview
7.5.3 Beohrigher Ingelheim Metabolic Disease Therapeutics Major Product Offerings
7.5.4 Beohrigher Ingelheim Metabolic Disease Therapeutics Revenue in Global Market (2017-2022)
7.5.5 Beohrigher Ingelheim Key News
7.6 KOWA
7.6.1 KOWA Corporate Summary
7.6.2 KOWA Business Overview
7.6.3 KOWA Metabolic Disease Therapeutics Major Product Offerings
7.6.4 KOWA Metabolic Disease Therapeutics Revenue in Global Market (2017-2022)
7.6.5 KOWA Key News
7.7 Kythera
7.7.1 Kythera Corporate Summary
7.7.2 Kythera Business Overview
7.7.3 Kythera Metabolic Disease Therapeutics Major Product Offerings
7.7.4 Kythera Metabolic Disease Therapeutics Revenue in Global Market (2017-2022)
7.7.5 Kythera Key News
7.8 Fuji yakuhin
7.8.1 Fuji yakuhin Corporate Summary
7.8.2 Fuji yakuhin Business Overview
7.8.3 Fuji yakuhin Metabolic Disease Therapeutics Major Product Offerings
7.8.4 Fuji yakuhin Metabolic Disease Therapeutics Revenue in Global Market (2017-2022)
7.8.5 Fuji yakuhin Key News
7.9 LG Life Science
7.9.1 LG Life Science Corporate Summary
7.9.2 LG Life Science Business Overview
7.9.3 LG Life Science Metabolic Disease Therapeutics Major Product Offerings
7.9.4 LG Life Science Metabolic Disease Therapeutics Revenue in Global Market (2017-2022)
7.9.5 LG Life Science Key News
7.10 Metsubishi Tanabe Pharma
7.10.1 Metsubishi Tanabe Pharma Corporate Summary
7.10.2 Metsubishi Tanabe Pharma Business Overview
7.10.3 Metsubishi Tanabe Pharma Metabolic Disease Therapeutics Major Product Offerings
7.10.4 Metsubishi Tanabe Pharma Metabolic Disease Therapeutics Revenue in Global Market (2017-2022)
7.10.5 Metsubishi Tanabe Pharma Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer